Staccato Loxapine Pulmonary Safety in Patients With COPD

NCT00889837 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

53

Enrollment

UNKNOWN

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: Inhaled Loxapine
DRUG: Inhaled Placebo

Sponsor

Alexza Pharmaceuticals, Inc.